Targeted Killing of Cancer Cellsin Vivoandin Vitrowith EGF-Directed Carbon Nanotube-Based Drug Delivery

644 indexed citations
published 2009

Countries where authors are citing Targeted Killing of Cancer Cellsin Vivoandin Vitrowith EGF-Directed Carbon Nanotube-Based Drug Delivery

Specialization
Citations

This map shows the geographic impact of Targeted Killing of Cancer Cellsin Vivoandin Vitrowith EGF-Directed Carbon Nanotube-Based Drug Delivery. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Targeted Killing of Cancer Cellsin Vivoandin Vitrowith EGF-Directed Carbon Nanotube-Based Drug Delivery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Targeted Killing of Cancer Cellsin Vivoandin Vitrowith EGF-Directed Carbon Nanotube-Based Drug Delivery more than expected).

Fields of papers citing Targeted Killing of Cancer Cellsin Vivoandin Vitrowith EGF-Directed Carbon Nanotube-Based Drug Delivery

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Targeted Killing of Cancer Cellsin Vivoandin Vitrowith EGF-Directed Carbon Nanotube-Based Drug Delivery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Targeted Killing of Cancer Cellsin Vivoandin Vitrowith EGF-Directed Carbon Nanotube-Based Drug Delivery.

About Targeted Killing of Cancer Cellsin Vivoandin Vitrowith EGF-Directed Carbon Nanotube-Based Drug Delivery

This paper, published in 2009, received 644 indexed citations . Written by Ashwin Bhirde, Vyomesh Patel, Julie Gavard, Guofeng Zhang, Alioscka A. Sousa, Andrius Masedunskas, Richard D. Leapman, Roberto Weigert, J. Silvio Gutkind and James F. Rusling covering the research area of Materials Chemistry, Biomedical Engineering and Biomaterials. It is primarily cited by scholars working on Biomedical Engineering (395 citations), Materials Chemistry (377 citations) and Biomaterials (212 citations). Published in ACS Nano.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1021/nn800551s.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026